Clinical-studies review · PMID 24003726
Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results — VialBase Research
Class-level clinical framing for Crystagen, whose own clinical data is absent.
Last updated · 2013 · Khavinson VKh et al. · Adv Gerontol
Key findings
- Summarises clinical results positioning Khavinson bioregulators as geroprotectors
- Family-level clinical context; no Crystagen-specific arm
Peptide bioregulators as geroprotectors — clinical results (PMID: 24003726)
Summary
A clinical-results summary for the Khavinson bioregulator class. Provides the family-level clinical context Crystagen is marketed within, with no Crystagen-specific data.
Relevance
Honest class-level support for Crystagen.
See Also
- Parent compound: Crystagen